Hepatocellular carcinoma: recent advances and emerging medical therapies [version 1; peer review: 2 approved]
Hepatocellular carcinoma remains a deadly disease with poor prognosis in patients with unresectable cancer. Trans-arterial chemoembolization is the primary locoregional therapy for intermediate-stage hepatocellular carcinoma, with an estimated median overall survival of less than two years. For almo...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
F1000 Research Ltd
2020-06-01
|
| Series: | F1000Research |
| Online Access: | https://f1000research.com/articles/9-620/v1 |